USTMA

Newly Diagnosed with CM-TMA / aHUS

Newly diagnosed

Newly Diagnosed with CM-TMA / aHUS?

A diagnosis of complement-mediated thrombotic microangiopathy (CM-TMA), historically called atypical hemolytic uremic syndrome (aHUS), can bring unfamiliar terminology and urgent questions. This guide focuses on the first things patients and families usually need: what CM-TMA means, why kidney and blood tests matter, how the diagnosis may be evaluated, and how to prepare for follow-up.

Start with the basics

Five things to know first

1

CM-TMA affects small blood vessels.

In CM-TMA, dysregulated complement activity can injure the lining of small blood vessels and contribute to microvascular clotting.

2

Blood and organs can both be affected.

Patients may have hemolytic anemia, a low platelet count, and organ injury. The kidneys are commonly involved, but other organs can be affected.

3

TTP must often be considered urgently.

TTP and CM-TMA can initially look similar. ADAMTS13 testing is an important part of evaluating an acute thrombotic microangiopathy.

4

Genetic testing is helpful, but it is not the whole diagnosis.

Some patients have complement-related genetic findings and others do not. A negative genetic test does not by itself rule out CM-TMA.

5

Long-term follow-up matters.

Follow-up may include kidney function, blood pressure, blood counts, hemolysis markers, treatment monitoring, pregnancy planning, and individualized recurrence risk.

Understanding the evaluation

CM-TMA is diagnosed by putting the whole clinical picture together.

Blood tests

Ask what your blood count, platelet count, LDH, haptoglobin, bilirubin, and blood smear show and how they are changing.

Kidney assessment

Ask about creatinine, urine findings, blood pressure, and whether nephrology should be involved in your care.

ADAMTS13

Ask whether ADAMTS13 testing was obtained and how your team is distinguishing CM-TMA from TTP and other causes of TMA.

Complement and genetics

Ask whether complement testing, genetic counseling, genetic testing, antibody testing, or other specialized evaluation is appropriate for your situation.

Questions for your care team

Write these down before your next visit.

  • What findings make you think this is CM-TMA / aHUS?
  • What other causes of TMA have been considered or ruled out?
  • How are my kidneys and other organs doing?
  • What treatment am I receiving, and what is the goal of each treatment?
  • What symptoms should prompt me to call you or seek emergency care?
  • Do I need genetic counseling or genetic testing?
  • What follow-up tests will I need after the acute episode?
  • Who should I contact after hours if I am worried about recurrence?
After the acute episode

Build a follow-up plan you can understand and use.

Your plan should be individualized. Ask your team how often they want to monitor kidney function, blood pressure, blood counts, hemolysis markers, treatment effects, and any other factors specific to your history.

You are not alone

Connect with the TMA community.